IHS Chemical Week

Regions :: North America :: U.S.

SAFC invests in ADCs, expands HPAPI capacity

8:36 AM MDT | October 14, 2013 | Deepti Ramesh

SAFC Commercial, the custom manufacturing and services business unit of Sigma-Aldrich, says it is expanding two of its manufacturing facilities in the United States to support drug manufacturers in bringing new targeted and cytotoxic therapies to market. SAFC is investing in commercial-scale manufacturing capacity for antibody drug conjugates (ADCs) at St. Louis, and expanding its high-potency active pharmaceutical ingredient (HPAPI) manufacturing and storage capacity at the Verona facility, near Madison, WI. The ADC expansion at the St. Louis site is expected to...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa